Skip to main content
. Author manuscript; available in PMC: 2011 Apr 6.
Published in final edited form as: J Pharm Biomed Anal. 2009 Nov 26;51(5):1120–1127. doi: 10.1016/j.jpba.2009.11.020

Table 3.

Pharmacokinetic parameters of matrine in rat plasma (n = 4) after i.v. and oral administration of matrine.

Parameter i.v. p.o.
Cmax (ng/ml) 94.6 ± 38.6
Tmax (min) 105 ± 30
AUC0–t (min ng/ml) 108,637 ± 11,801 18,453 ± 5885
AUC0–∞ (min ng/ml) 108,794 ± 11,712 18,593 ± 5931
t½ (min) 142 ± 79 92 ± 32
Ke (1/min) 0.0060 ± 0.0030 0.0081 ± 0.0023
V (ml/kg) 3704 ± 1874 2433 ± 1668
CL (ml/min/kg) 18.6 ± 2.0 19.7 ± 5.5
Bioavailability (%) 17.1 ± 5.4